31 May 2026
Strategic Healthcare
Finance

Armistice AUM Expansion Marked by Strategic Healthcare and Biotech Investment Portfolio 

In recent market developments, Armistice Capital has demonstrated a focused investment strategy across specialized healthcare sectors, with notable allocations in ophthalmic research, women’s health technologies, and biotechnology innovations. The firm’s investment decisions reflect a methodical approach to identifying promising medical advancements and therapeutic breakthroughs. The…